Divya Grover

Latest articles

6h
Channel NewsAsia
Allergan, Richter depression drug succeeds key trialcariprazine, sold under the brand name Vraylar, is already approved to treat ma
Channel NewsAsia / Posted 6 hours ago
cariprazine, sold under the brand name Vraylar, is already approved to treat manic or mixed episodes of bipolar depression and schizophrenia in adults. (Reporting by Divya Grover in Bengaluru; Editing by Martina D'Cou... Read more
5d
Channel NewsAsia
Revance will wait to seek backing for Botox-rivalthe market until mid-2020 and we do not believe this data will support a longer
Channel NewsAsia / Posted 5 days ago
the market until mid-2020 and we do not believe this data will support a longer duration claim," spokesman Mark Marmur said in an email. (Reporting by Divya Grover in Bengaluru; editing by Patrick Graham and Saumyadeb Chakrabarty)Source:... Read more
12d
Channel NewsAsia
FDA proposes drug development guidance for rare pediatric diseasesbreak down certain fats, leading to enlarged liver and spleen. The guidance is
Channel NewsAsia / Posted 12 days ago
break down certain fats, leading to enlarged liver and spleen. The guidance is available for comment for about two months, after which the FDA will release its final determinations. (Reporting by Divya Grover in Bengaluru; Editing by Anil D'S... Read more
12d
Channel NewsAsia
UnitedHealth to buy DaVita's medical unit for US$4.9 billiontrading, while UnitedHealth's shares were slightly lower. Reuters reported las
Channel NewsAsia / Posted 12 days ago
trading, while UnitedHealth's shares were slightly lower. Reuters reported last month that DaVita was exploring a sale of its medical unit. (Reporting by Divya Grover in Bengaluru; Editing by Arun Koyyur and Sai Sachin Ravikumar)Source:... Read more
13d
Channel NewsAsia
Shire in deal to develop a new way to administer hemophilia drugcompletion of certain studies. Hemophilia is a chronic disease that causes lon
Channel NewsAsia / Posted 13 days ago
completion of certain studies. Hemophilia is a chronic disease that causes longer-than-normal bleeding due to absent or deficient clotting factor in the blood. (Reporting by Divya Grover in Bengaluru; Editing by Sriraj Kalluvila)Source:... Read more
21d
Channel NewsAsia
Biogen boosts multiple sclerosis holding with Alkermes licenseData from this study is expected in the first half of 2018. Biogen's shares we
Channel NewsAsia / Posted 21 days ago
Data from this study is expected in the first half of 2018. Biogen's shares were little changed in early trading on Monday, while Alkermes dipped 0.7 percent. (Reporting by Divya Grover in Bengaluru; Editing by Savio D'Souza)Sou... Read more
28d
Channel NewsAsia
Reimbursement cuts on lab tests pressure US lab firm sharessaid. The company's shares were up 4 percent on Monday. Shares of Genomic and
Channel NewsAsia / Posted 28 days ago
said. The company's shares were up 4 percent on Monday. Shares of Genomic and Veracyte were flat on Monday, while those of CareDx were up 2 percent. (Reporting by Divya Grover in Bengaluru; Editing by Sayantani Ghosh and Anil D'Silva)Source: Reut... Read more

In this news